NCT00004757View on ClinicalTrials.gov

Phase III Randomized, Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection Limited to the Skin, Eyes, and Mouth

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 1992

Conditions
Herpes Simplex
Interventions
DRUG

acyclovir

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

National Center for Research Resources (NCRR)

NIH